LEADER 01489nas  2200481 a 450 
001 9910144034803321
005 20240413020418.0
011   $a1099-1557
035   $a(OCoLC)44084438
035   $a(CKB)954925595523
035   $a(CONSER)  2001212290
035   $a(DE-599)ZDB1491218-1
035   $a(EXLCZ)99954925595523
100   $a20000519a19929999  sy         a
101 0 $aeng
135   $aurmnu---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmacoepidemiology and drug safety
210  1$a[Chichester] :$cJohn Wiley & Sons,$d1992-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311   $a1053-8569 
606   $aDrug Utilization
606   $aDrug-Related Side Effects and Adverse Reactions
606   $aEpidemiologic Methods
606   $aEpidemiology
606   $aPharmacology, Clinical
606   $aProduct Surveillance, Postmarketing
615  2$aDrug Utilization.
615  2$aDrug-Related Side Effects and Adverse Reactions.
615  2$aEpidemiologic Methods.
615  2$aEpidemiology.
615  2$aPharmacology, Clinical.
615  2$aProduct Surveillance, Postmarketing.
676   $a615
712 02$aInternational Society for Pharmacoepidemiology,
712 02$aInternational Society of Pharmacovigilance,
906   $aJOURNAL
912   $a9910144034803321
996   $aPharmacoepidemiology and drug safety$92023300
997   $aUNINA